Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A... Tender

DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Lenograstim, Atc L03aa10 for the Period November 1St, 2023 - October 31St, 2025. The project location is Germany and the tender is closing on 05 Sep 2025. The tender notice number is 566240-2023, while the TOT Ref Number is 89208707. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country: Germany

Summary: Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Lenograstim, Atc L03aa10 for the Period November 1St, 2023 - October 31St, 2025

Deadline: 05 Sep 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 89208707

Document Ref. No.: 566240-2023

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: EUR 1.00

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, seeet a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicines to be specified by the bidder in Annex 2 to the contract in relation to the above. The active ingredient, Lenograstim, ATC L03AA10, is intended by DAK-Gesund ability to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into force. A discount contract in the form of an approval model for the above-mentioned. The active ingredient comes into force for the first time on November 1st, 2023 and ends on October 31st, 2025. Heregardless of this, ends automatically when the exclusive contract comes into force.

Doc Title: Pharmaceutical products

Contract Type: Supplies
Document Type : Contract notice
Reference Number : 1004065 - Lenograstim, ATC L03AA10
Contract Type : Supplies
Estimated Value : 1.00 - EUR
33600000 - Pharmaceutical products
Authority Type : Body governed by public law
Type of Procedure : Open procedure
Regulation : European Union
Bid Type : Submission for all lots
Doc Title : Pharmaceutical products
Dispatch Date : 2023-09-15
Publish Date : 2023-09-20
Submission Date : 2025-09-05

Documents

 Tender Notice


Procurement Documents for Germany

Access a comprehensive library of standard procurement documents specific to Germany. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Germany

Explore Procurement Documents for Germany


Want To Bid in This Tender?

Get Local Agent Support in Germany and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?